{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:19:33Z","timestamp":1778692773035,"version":"3.51.4"},"reference-count":70,"publisher":"Elsevier BV","issue":"4","funder":[{"DOI":"10.13039\/501100001809","name":"National natural science foundation of china","doi-asserted-by":"publisher","award":["81573456"],"award-info":[{"award-number":["81573456"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMP"],"published-print":{"date-parts":[[2019,10,15]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Aggressive behavior of tumor metastasis comes from certain mutations, changes in cellular metabolic and signaling pathways that are majorly altered by tumor microenvironment (TME), its other components and growth factors like transforming growth factor-\u03b21 (TGF-\u03b21) which is chiefly known for its epithelial to mesenchymal transformation (EMT). EMT is a critical step of metastasis cascade in actual human lung cancer scenario.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>Our present study is focused on unveiling the in-vivo metastatic behavior of TGF-\u03b21 treated lung cancer cells that undergo EMT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>The lung cancer epithelial A549 cells were treated in-vitro with TGF-\u03b21 (3-5ng\/ml for 72 h) for EMT. After confirming the transformation of cells by phenotype modifications, wound healing and cell migration assay and qRT-PCR analyses of EMT biomarkers including E. Cadherin, Vimentin, Snail, Slug, MMP2 and MMP9; those TGF-\u03b21 modified cells were probed with fluorescent trackers and were injected into the tail vein of BALB\/c nude mice for metastatic dissemination studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Our findings indicate that the distribution of TGF-\u03b21 treated A549 cells as compared to W.T A549 towards lungs is less in terms of total relative fluorescent cluster count, however, the difference is insignificant (52\u00b14, 60\u00b15 respectively). Additionally, we show that TGF-\u03b21 treated cells tend to metastasize almost 2, 3, 1.5, 2 and 1.7 times more than W.T towards liver, brain, ovaries, bones and adrenal gland, respectively, which is very much like human lung cancer metastasis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Conclusively, it is the first study ever reporting that a pre-treatment of cells with TGF-\u03b21 for experimental lung cancer metastasis mouse model may portray a more precise approach for the development of potential therapeutic treatments. Additional pre-treatment studies with the application of other TME conditions like hypoxia and factors like NF\u03baB, VEGF etc. may be a future prospect to develop a better understanding.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1874467212666190306165703","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T11:33:12Z","timestamp":1552044792000},"page":"249-260","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["In-vitro Pre-Treatment of Cancer Cells with TGF-\u03b21: A Novel Approach of Tail Vein Lung Cancer Metastasis Mouse Model for Anti-Metastatic Studies"],"prefix":"10.1016","volume":"12","author":[{"given":"Ghulam Jilany","family":"Khan","sequence":"first","affiliation":[{"name":"Jiangsu key laboratory of Drug Screening, China Pharmaceutical University, Nanjing 210009, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[{"name":"Jiangsu key laboratory of Drug Screening, China Pharmaceutical University, Nanjing 210009, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Abbas","sequence":"additional","affiliation":[{"name":"State key Laboratory of Pharmaceutical Biotechnology, Nanjing University, 210023, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Naveed","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, School of Pharmacy, Nanjing Medical University, 211166, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talha","family":"Jamshaid","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, The Islamia University of Bahawalpur, Bahawalpur, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirza Muhammad Faran Ashraf","family":"Baig","sequence":"additional","affiliation":[{"name":"State Key Laboratory of analytical chemistry for life sciences, Nanjing University, 210023, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengtao","family":"Yuan","sequence":"additional","affiliation":[{"name":"Jiangsu key laboratory of Drug Screening, China Pharmaceutical University, Nanjing 210009, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","volume":"25","author":"Torre L.A.","year":"2016","unstructured":"Torre L.A.; Siegel R.L.; Ward E.M.; Jemal A.; Global Cancer Incidence and Mortality Rates and Trends--An Update. Cancer Epidemiol Biomarkers Prev 2016,25(1),16-27","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.currproblcancer.2018.08.003","volume":"43","author":"Abbas M.","year":"2019","unstructured":"Abbas M.; Ahmed A.; Khan G.J.; Baig M.M.F.A.; Naveed M.; Mikrani R.; Cao T.; Naeem S.; Shi M.; Dingding C.; Clinical evaluation of carcinoembryonic and carbohydrate antigens as cancer biomarkers to monitor palliative chemotherapy in advanced stage gastric cancer. Curr Probl Cancer 2019,43(1),5-17","journal-title":"Curr Probl Cancer"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.biopha.2018.04.178","volume":"103","author":"Abbas M.","year":"2018","unstructured":"Abbas M.; Faggian A.; Sintali D.N.; Khan G.J.; Naeem S.; Shi M.; Dingding C.; Current and future biomarkers in gastric cancer. Biomed Pharmacother 2018,103,1688-1700","journal-title":"Biomed Pharmacother"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.7314\/APJCP.2014.15.12.4877","volume":"15","author":"Khan G.J.","year":"2014","unstructured":"Khan G.J.; Naeem H.S.; Khan S.; Jamshaid T.; Sajid M.I.; Bashir I.; Jamshaid M.; Understanding and responsiveness level about cervical cancer and its avoidance among young women of Pakistan. Asian Pac J Cancer Prev 2014,15(12),4877-4883","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"Torre L.A.","year":"2015","unstructured":"Torre L.A.; Bray F.; Siegel R.L.; Ferlay J.; Lortet-Tieulent J.; Jemal A.; Global cancer statistics, 2012. CA Cancer J Clin 2015,65(2),87-108","journal-title":"CA Cancer J Clin"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.7314\/APJCP.2014.15.12.4877","volume":"15","author":"Khan G.J.","year":"2014","unstructured":"Khan G.J.; Naeem H.S.; Khan S.; Jamshaid T.; Sajid M.I.; Bashir I.; Jamshaid M.; Understanding and responsiveness level about cervical cancer and its avoidance among young women of Pakistan. Asian Pac J Cancer Prev 2014,15(12),4877-4883","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.2174\/1389450119666180219124439","volume":"19","author":"Khan G.J.","year":"2018","unstructured":"Khan G.J.; Sun L.; Khan S.; Yuan S.; Nongyue H.; Versatility of Cancer Associated Fibroblasts: Commendable Targets for Anti-tumor Therapy. Curr Drug Targets 2018,19(13),1573-1588","journal-title":"Curr Drug Targets"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/1097-0142(197501)35:1<98:AID-CNCR2820350115>3.0.CO;2-B","volume":"35","author":"DeVita V.T.","year":"1975","unstructured":"DeVita V.T.; Young R.C.; Canellos G.P.; Combination versus single agent chemotherapy: a review of the basis for selection of drug treatment of cancer. Cancer 1975,35(1),98-110","journal-title":"Cancer"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2174\/1568009617666170807120304","volume":"18","author":"Khan G.J.","year":"2018","unstructured":"Khan G.J.; Gao Y.; Gu M.; Wang L.; Khan S.; Naeem F.; Semukunzi H.; Roy D.; Yuan S.; Sun L.; TGF-\u03b21 Causes EMT by Regulating N-Acetyl Glucosaminyl Transferases via Downregulation of Non Muscle Myosin II-A through JNK\/P38\/PI3K Pathway in Lung Cancer. Curr Cancer Drug Targets 2018,18(2),209-219","journal-title":"Curr Cancer Drug Targets"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10555-016-9618-0","volume":"35","author":"Popper H.H.","year":"2016","unstructured":"Popper H.H.; Progression and metastasis of lung cancer. Cancer Metastasis Rev 2016,35(1),75-91","journal-title":"Cancer Metastasis Rev"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.ejcts.2003.11.033","volume":"25","author":"Gabor S.","year":"2004","unstructured":"Gabor S.; Renner H.; Popper H.; Anegg U.; Sankin O.; Matzi V.; Lindenmann J.; Smolle J\u00fcttner F.M.; Invasion of blood vessels as significant prognostic factor in radically resected T1-3N0M0 non-small-cell lung cancer. Eur J Cardiothorac Surg 2004,25(3),439-442","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/JTO.0000000000000069","volume":"9","author":"Shin D.Y.","year":"2014","unstructured":"Shin D.Y.; Na I.I.; Kim C.H.; Park S.; Baek H.; Yang S.H.; EGFR mutation and brain metastasis in pulmonary adenocarcinomas. J Thorac Oncol 2014,9(2),195-199","journal-title":"J Thorac Oncol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3892\/mco.2014.410","volume":"3","author":"Tamura T.","year":"2015","unstructured":"Tamura T.; Kurishima K.; Nakazawa K.; Kagohashi K.; Ishikawa H.; Satoh H.; Hizawa N.; Specific organ metastases and survival in metastatic non-small-cell lung cancer. Mol Clin Oncol 2015,3(1),217-221","journal-title":"Mol Clin Oncol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.lungcan.2014.01.006","volume":"84","author":"Hendriks L.E.L.","year":"2014","unstructured":"Hendriks L.E.L.; Smit E.F.; Vosse B.A.H.; Mellema W.W.; Heideman D.A.M.; Bootsma G.P.; Westenend M.; Pitz C.; de Vries G.J.; Houben R.; Gr\u00fcnberg K.; Bendek M.; Speel E.J.; Dingemans A.M.; EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases? Lung Cancer 2014,84(1),86-91","journal-title":"Lung Cancer"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.bbamem.2008.11.005","volume":"1788","author":"Martin T.A.","year":"2009","unstructured":"Martin T.A.; Jiang W.G.; Loss of tight junction barrier function and its role in cancer metastasis. Biochim Biophys Acta 2009,1788(4),872-891","journal-title":"Biochim Biophys Acta"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/cr.2008.316","volume":"19","author":"Padua D.","year":"2009","unstructured":"Padua D.; Massagu\u00e9 J.; Roles of TGFbeta in metastasis. Cell Res 2009,19(1),89-102","journal-title":"Cell Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.cyto.2017.09.026","volume":"103","author":"Wang X.","year":"2018","unstructured":"Wang X.; Hassan W.; Jabeen Q.; Khan G.J.; Iqbal F.; Interdependent and independent multidimensional role of tumor microenvironment on hepatocellular carcinoma. Cytokine 2018,103,150-159","journal-title":"Cytokine"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.drudis.2018.09.007","volume":"24","author":"Yang T.","year":"2019","unstructured":"Yang T.; Khan G.J.; Wu Z.; Wang X.; Zhang L.; Jiang Z.; Bile acid homeostasis paradigm and its connotation with cholestatic liver diseases. Drug Discov Today 2019,24(1),112-128","journal-title":"Drug Discov Today"},{"key":"ref=19","author":"Martin T.A.","unstructured":"Martin T.A.; Ye L.; Sanders A.J.; Lane J.; Jiang W.G.; Cancer Invasion and Metastasis Molecular and Cellular Perspective. In: Madame Curie Bioscience Database. Austin (TX): Landes Bioscience; 2000-2013, [Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK164700]"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3892\/or.2016.4879","volume":"36","author":"Wei X.H.","year":"2016","unstructured":"Wei X.H.; Lin S.S.; Liu Y.; Zhao R.P.; Khan G.J.; Du H.Z.; Mao T.T.; Yu B.Y.; Li R.M.; Yuan S.T.; Sun L.; DT-13 attenuates human lung cancer metastasis via regulating NMIIA activity under hypoxia condition. Oncol Rep 2016,36(2),991-999","journal-title":"Oncol Rep"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3892\/or.2016.4890","volume":"36","author":"Du H.","year":"2016","unstructured":"Du H.; Huang Y.; Hou X.; Yu X.; Lin S.; Wei X.; Li R.; Khan G.J.; Yuan S.; Sun L.; DT-13 inhibits cancer cell migration by regulating NMIIA indirectly in the tumor microenvironment. Oncol Rep 2016,36(2),721-728","journal-title":"Oncol Rep"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.mrrev.2011.05.002","volume":"728","author":"van Zijl F.","year":"2011","unstructured":"van Zijl F.; Krupitza G.; Mikulits W.; Initial steps of metastasis: cell invasion and endothelial transmigration. Mutat Res 2011,728(1-2),23-34","journal-title":"Mutat Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1056\/NEJMra0805239","volume":"359","author":"Chiang A.C.","year":"2008","unstructured":"Chiang A.C.; Massagu\u00e9 J.; Molecular basis of metastasis. N Engl J Med 2008,359(26),2814-2823","journal-title":"N Engl J Med"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrg2101","volume":"8","author":"Nguyen D.X.","year":"2007","unstructured":"Nguyen D.X.; Massagu\u00e9 J.; Genetic determinants of cancer metastasis. Nat Rev Genet 2007,8(5),341-352","journal-title":"Nat Rev Genet"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ejphar.2016.04.016","volume":"781","author":"Li H.","year":"2016","unstructured":"Li H.; Sun L.; de Carvalho E.L.; Li X.; Lv X.; Khan G.J.; Semukunzi H.; Yuan S.; Lin S.; DT-13, a saponin monomer of dwarf lilyturf tuber, induces autophagy and potentiates anti-cancer effect of nutrient deprivation. Eur J Pharmacol 2016,781,164-172","journal-title":"Eur J Pharmacol"},{"key":"ref=26","first-page":"764","volume":"4","author":"Khan G.J.","year":"2013","unstructured":"Khan G.J.; Omer M.O.; Ashraf M.; Rehman H.U.; Khan Z.U.D.; Effect of Punica granatum (pomegranate) fruit extract on angiogenesis. J App Pharm 2013,4(02),764-780","journal-title":"J App Pharm"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.11648\/j.crj.20140203.12","volume":"2","author":"Khan G.J.","year":"2014","unstructured":"Khan G.J.; Shakir L.; Khan S.; Naeem H.S.; Omer M.O.; Assessment methods of angiogenesis and present approaches for its quantification. Cancer Res J (N Y N Y) 2014,2(3),47-62","journal-title":"Cancer Res J (N Y N Y)"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/nrc3603","volume":"13","author":"Pickup M.","year":"2013","unstructured":"Pickup M.; Novitskiy S.; Moses H.L.; The roles of TGF\u03b2 in the tumour microenvironment. Nat Rev Cancer 2013,13(11),788-799","journal-title":"Nat Rev Cancer"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/jcb.21159","volume":"101","author":"Li H.","year":"2007","unstructured":"Li H.; Fan X.; Houghton J.; Tumor microenvironment: the role of the tumor stroma in cancer. J Cell Biochem 2007,101(4),805-815","journal-title":"J Cell Biochem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.canlet.2010.06.004","volume":"298","author":"Feng R.","year":"2010","unstructured":"Feng R.; Chen X.; Yu Y.; Su L.; Yu B.; Li J.; Cai Q.; Yan M.; Liu B.; Zhu Z.; miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett 2010,298(1),50-63","journal-title":"Cancer Lett"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10549-010-1244-x","volume":"127","author":"Yang R.","year":"2011","unstructured":"Yang R.; Dick M.; Marme F.; Schneeweiss A.; Langheinz A.; Hemminki K.; Sutter C.; Bugert P.; Wappenschmidt B.; Varon R.; Schott S.; Weber B.H.; Niederacher D.; Arnold N.; Meindl A.; Bartram C.R.; Schmutzler R.K.; M\u00fcller H.; Arndt V.; Brenner H.; Sohn C.; Burwinkel B.; Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk. Breast Cancer Res Treat 2011,127(2),549-554","journal-title":"Breast Cancer Res Treat"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3390\/molecules23051083","volume":"23","author":"Huyen C.T.T.","year":"2018","unstructured":"Huyen C.T.T.; Luyen B.T.T.; Khan G.J.; Oanh H.V.; Hung T.M.; Li H-J.; Li P.; Chemical Constituents from Cimicifuga dahurica and Their Anti-Proliferative Effects on MCF-7 Breast Cancer Cells. Molecules 2018,23(5),1083","journal-title":"Molecules"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3390\/ijms19020573","volume":"19","author":"Rwibasira R.G.","year":"2018","unstructured":"Rwibasira R.G.; Khan G.J.; Kong Y.; Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy. Int J Mol Sci 2018,19(2),573","journal-title":"Int J Mol Sci"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1615\/CritRevOncog.v18.i1-2.40","volume":"18","author":"Seyfried T.N.","year":"2013","unstructured":"Seyfried T.N.; Huysentruyt L.C.; On the origin of cancer metastasis. Crit Rev Oncog 2013,18(1-2),43-73","journal-title":"Crit Rev Oncog"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"Quail D.F.","year":"2013","unstructured":"Quail D.F.; Joyce J.A.; Microenvironmental regulation of tumor progression and metastasis. Nat Med 2013,19(11),1423-1437","journal-title":"Nat Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.biopha.2017.02.083","volume":"89","author":"Semukunzi H.","year":"2017","unstructured":"Semukunzi H.; Roy D.; Li H.; Khan G.J.; Lyu X.; Yuan S.; Lin S.; IDH mutations associated impact on related cancer epidemiology and subsequent effect toward HIF-1\u03b1. Biomed Pharmacother 2017,89,805-811","journal-title":"Biomed Pharmacother"},{"key":"ref=37","first-page":"457","volume":"74","author":"Hoffman R.M.","year":"2003","unstructured":"Hoffman R.M.; Metastatic orthotopic mouse models of lung cancer. Methods Mol Med 2003,74,457-464","journal-title":"Methods Mol Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/978-0-387-68113-9_37","author":"Davis J.M.","year":"2008","unstructured":"Davis J.M.; Casey K.K.; Surgery in the Immunocompromised PatientSurgery: Basic Science and Clinical Evidence; Norton, JA; Barie, PS; Bollinger, RR; Chang, AE; Lowry, SF; Mulvihill, SJ; Pass, HI; Thompson, RW Eds.; Springer New York: New York, NY,2008,697-707","journal-title":"Surgery in the Immunocompromised PatientSurgery: Basic Science and Clinical Evidence; Norton, JA; Barie, PS; Bollinger, RR; Chang, AE; Lowry, SF; Mulvihill, SJ; Pass, HI; Thompson, RW"},{"key":"ref=39","first-page":"701","volume":"18","author":"Girard J.P.","year":"1977","unstructured":"Girard J.P.; Cuevas M.; Effects of anesthesia and surgery on certain parameters of humoral immunity. Ann Anesthesiol Fr 1977,18(7-8),701-707","journal-title":"Ann Anesthesiol Fr"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/0022-4804(67)90089-3","volume":"7","author":"Wingard D.W.","year":"1967","unstructured":"Wingard D.W.; Lang R.; Humphrey L.J.; Effect of anesthesia on immunity. J Surg Res 1967,7(9),430-432","journal-title":"J Surg Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.1158\/0008-5472.CAN-09-3312","volume":"70","author":"Malik G.","year":"2010","unstructured":"Malik G.; Knowles L.M.; Dhir R.; Xu S.; Yang S.; Ruoslahti E.; Pilch J.; Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion. Cancer Res 2010,70(11),4327-4334","journal-title":"Cancer Res"},{"key":"ref=42","first-page":"5","volume":"31","author":"Ruf W.","year":"2001","unstructured":"Ruf W.; Molecular regulation of blood clotting in tumor biology. Haemostasis 2001,31(Suppl. 1),5-7","journal-title":"Haemostasis"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.molonc.2013.02.009","volume":"7","author":"Saxena M.","year":"2013","unstructured":"Saxena M.; Christofori G.; Rebuilding cancer metastasis in the mouse. Mol Oncol 2013,7(2),283-296","journal-title":"Mol Oncol"},{"key":"ref=44","first-page":"2033","author":"Shields A.F.","year":"2007","unstructured":"Shields A.F.; Price P.M.D.; Mcconville P.; Elliott W.L.; Rajendran J.G.; Mankoff D.A.; Evelhoch J.L.; Ken Miles M.D.; Weber W.A.; In vivo imaging of cancer therapy 2007,2033","journal-title":"In vivo imaging of cancer therapy"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/BF00049477","volume":"1","author":"Hart I.R.","year":"1982","unstructured":"Hart I.R.; \u2018Seed and soil\u2019 revisited: mechanisms of site-specific metastasis. Cancer Metastasis Rev 1982,1(1),5-16","journal-title":"Cancer Metastasis Rev"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrc1098","volume":"3","author":"Fidler I.J.","year":"2003","unstructured":"Fidler I.J.; The pathogenesis of cancer metastasis: the \u2018seed and soil\u2019 hypothesis revisited. Nat Rev Cancer 2003,3(6),453-458","journal-title":"Nat Rev Cancer"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"6073","DOI":"10.1021\/acs.jafc.8b02241","volume":"66","author":"Zhai K.F.","year":"2018","unstructured":"Zhai K.F.; Duan H.; Khan G.J.; Xu H.; Han F.K.; Cao W.G.; Gao G.Z.; Shan L.L.; Wei Z-J.; Salicin from Alangium chinense Ameliorates Rheumatoid Arthritis by Modulating the Nrf2-HO-1-ROS Pathways. J Agric Food Chem 2018,66(24),6073-6082","journal-title":"J Agric Food Chem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1039\/C7FO01748K","volume":"9","author":"Zhai K.F.","year":"2018","unstructured":"Zhai K.F.; Duan H.; Chen Y.; Khan G.J.; Cao W.G.; Gao G.Z.; Shan L.L.; Wei Z.J.; Apoptosis effects of imperatorin on synoviocytes in rheumatoid arthritis through mitochondrial\/caspase-mediated pathways. Food Funct 2018,9(4),2070-2079","journal-title":"Food Funct"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.biopha.2017.11.059","volume":"97","author":"Baig M.M.F.A.","year":"2018","unstructured":"Baig M.M.F.A.; Khan S.; Naeem M.A.; Khan G.J.; Ansari M.T.; Vildagliptin loaded triangular DNA nanospheres coated with eudragit for oral delivery and better glycemic control in type 2 diabetes mellitus. Biomed Pharmacother 2018,97,1250-1258","journal-title":"Biomed Pharmacother"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.biopha.2017.10.101","volume":"97","author":"Khan G.J.","year":"2018","unstructured":"Khan G.J.; Rizwan M.; Abbas M.; Naveed M.; Boyang Y.; Naeem M.A.; Khan S.; Yuan S.; Baig M.M.F.A.; Sun L.; Pharmacological effects and potential therapeutic targets of DT-13. Biomed Pharmacother 2018,97,255-263","journal-title":"Biomed Pharmacother"},{"key":"ref=51","first-page":"703","volume":"23","author":"Tajdin F.","year":"2013","unstructured":"Tajdin F.; Rasheed M.A.; Ashraf M.; Rasheed H.; Ejaz H.; Khan G.J.; Antibiotic therapy in pyogenic meningitis in paediatric patients. J Coll Physicians Surg Pak 2013,23(10),703-707","journal-title":"J Coll Physicians Surg Pak"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"H0034","DOI":"10.1186\/gb-2002-3-7-research0034","volume":"3","author":"Vandesompele J.","year":"2002","unstructured":"Vandesompele J.; De Preter K.; Pattyn F.; Poppe B.; Van Roy N.; De Paepe A.; Speleman F.; Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002,3(7),H0034","journal-title":"Genome Biol"},{"key":"ref=53","first-page":"20516","volume":"8","author":"An Q.","year":"2015","unstructured":"An Q.; Han C.; Zhou Y.; Li F.; Li D.; Zhang X.; Yu Z.; Duan Z.; Kan Q.; In vitro effects of mitomycin C on the proliferation of the non-small-cell lung cancer line A549. Int J Clin Exp Med 2015,8(11),20516-20523","journal-title":"Int J Clin Exp Med"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1177\/1758834014521110","volume":"6","author":"D\u2019Antonio C.","year":"2014","unstructured":"D\u2019Antonio C.; Passaro A.; Gori B.; Del Signore E.; Migliorino M.R.; Ricciardi S.; Fulvi A.; de Marinis F.; Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies. Ther Adv Med Oncol 2014,6(3),101-114","journal-title":"Ther Adv Med Oncol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3389\/fonc.2014.00248","volume":"4","author":"Owen S.","year":"2014","unstructured":"Owen S.; Souhami L.; The management of brain metastases in non-small cell lung cancer. Front Oncol 2014,4(12),248","journal-title":"Front Oncol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1186\/1471-2407-14-416","volume":"14","author":"Deberne M.","year":"2014","unstructured":"Deberne M.; Ropert S.; Billemont B.; Daniel C.; Chapron J.; Goldwasser F.; Inaugural bone metastases in non-small cell lung cancer: a specific prognostic entity? BMC Cancer 2014,14(1),416","journal-title":"BMC Cancer"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3389\/fonc.2016.00257","volume":"6","author":"Weber G.F.","year":"2016","unstructured":"Weber G.F.; Time and Circumstances: Cancer Cell Metabolism at Various Stages of Disease Progression. Front Oncol 2016,6(12),257","journal-title":"Front Oncol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"Hanahan D.","year":"2011","unstructured":"Hanahan D.; Weinberg R.A.; Hallmarks of cancer: the next generation. Cell 2011,144(5),646-674","journal-title":"Cell"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.cell.2012.02.032","volume":"148","author":"DeBerardinis R.J.","year":"2012","unstructured":"DeBerardinis R.J.; Thompson C.B.; Cellular metabolism and disease: what do metabolic outliers teach us? Cell 2012,148(6),1132-1144","journal-title":"Cell"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","volume":"49","author":"Reuter S.","year":"2010","unstructured":"Reuter S.; Gupta S.C.; Chaturvedi M.M.; Aggarwal B.B.; Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 2010,49(11),1603-1616","journal-title":"Free Radic Biol Med"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.1158\/1078-0432.CCR-12-0977","volume":"18","author":"Miller D.M.","year":"2012","unstructured":"Miller D.M.; Thomas S.D.; Islam A.; Muench D.; Sedoris K.; c-Myc and cancer metabolism. Clin Cancer Res 2012,18(20),5546-5553","journal-title":"Clin Cancer Res"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"Valastyan S.","year":"2011","unstructured":"Valastyan S.; Weinberg R.A.; Tumor metastasis: molecular insights and evolving paradigms. Cell 2011,147(2),275-292","journal-title":"Cell"},{"key":"ref=63","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3031459","volume":"2016","author":"Palmirotta R.","year":"2016","unstructured":"Palmirotta R.; Cives M.; Della-Morte D.; Capuani B.; Lauro D.; Guadagni F.; Silvestris F.; Sirtuins and Cancer: Role in the Epithelial-Mesenchymal Transition. Oxid Med Cell Longev 2016,2016(3)","journal-title":"Oxid Med Cell Longev"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40169-015-0048-3","volume":"4","author":"Heerboth S.","year":"2015","unstructured":"Heerboth S.; Housman G.; Leary M.; Longacre M.; Byler S.; Lapinska K.; Willbanks A.; Sarkar S.; EMT and tumor metastasis. Clin Transl Med 2015,4(1),6","journal-title":"Clin Transl Med"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1080\/15384101.2015.1063296","volume":"14","author":"Wei S.C.","year":"2015","unstructured":"Wei S.C.; Fattet L.; Yang J.; The forces behind EMT and tumor metastasis. Cell Cycle 2015,14(15),2387-2388","journal-title":"Cell Cycle"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.lungcan.2014.07.020","volume":"86","author":"Riihim\u00e4ki M.","year":"2014","unstructured":"Riihim\u00e4ki M.; Hemminki A.; Fallah M.; Thomsen H.; Sundquist K.; Sundquist J.; Hemminki K.; Metastatic sites and survival in lung cancer. Lung Cancer 2014,86(1),78-84","journal-title":"Lung Cancer"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3892\/mco.2014.410","volume":"3","author":"Tamura T.","year":"2015","unstructured":"Tamura T.; Kurishima K.; Nakazawa K.; Kagohashi K.; Ishikawa H.; Satoh H.; Hizawa N.; Specific organ metastases and survival in metastatic non-small-cell lung cancer. Mol Clin Oncol 2015,3(1),217-221","journal-title":"Mol Clin Oncol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/cmi.2015.96","volume":"13","author":"Peng H.","year":"2016","unstructured":"Peng H.; Wisse E.; Tian Z.; Liver natural killer cells: subsets and roles in liver immunity. Cell Mol Immunol 2016,13(3),328-336","journal-title":"Cell Mol Immunol"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1189\/jlb.72.4.668","volume":"72","author":"Vermijlen D.","year":"2002","unstructured":"Vermijlen D.; Luo D.; Froelich C.J.; Medema J.P.; Kummer J.A.; Willems E.; Braet F.; Wisse E.; Hepatic natural killer cells exclusively kill splenic\/blood natural killer-resistant tumor cells by the perforin\/granzyme pathway. J Leukoc Biol 2002,72(4),668-676","journal-title":"J Leukoc Biol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1503\/cmaj.1040752","volume":"172","author":"Giannini E.G.","year":"2005","unstructured":"Giannini E.G.; Testa R.; Savarino V.; Liver enzyme alteration: a guide for clinicians. CMAJ 2005,172(3),367-379","journal-title":"CMAJ"}],"container-title":["Current Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/170514","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T22:56:36Z","timestamp":1746572196000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/170514\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,15]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10,15]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1874467212666190306165703","relation":{},"ISSN":["1874-4672"],"issn-type":[{"value":"1874-4672","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,15]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-09-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}